| ATCC 35274| CIP 106513| Oxalobacter formigenes| Oxalobacter formigenes Allison et al. 1985| strain OxB
Oxalate Metabolism: Oxalobacter formigenes is known for its unique ability to break down and metabolize oxalate in the colon. By doing so, it may help reduce the absorption of oxalate in the intestines, potentially lowering the risk of oxalate-related conditions, such as the formation of kidney stones.
Kidney Stone Prevention: Some studies suggest that individuals with higher levels of Oxalobacter formigenes in their gut may have a lower risk of developing kidney stones. The bacteria's ability to degrade oxalate may contribute to a reduction in urinary oxalate levels, which is associated with a decreased risk of calcium oxalate kidney stone formation.
Gut Microbiota and Health: Oxalobacter formigenes is a part of the complex community of microorganisms in the human gut. While much of the research has focused on its role in oxalate metabolism, there is ongoing exploration of the broader interactions between gut microbiota and human health. A balanced and diverse gut microbiota is generally considered beneficial for overall health.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.77 | 1 | 600 | 0 | 503 | 163.5 | 106 | 173.4 | 0 | 468 | 0 %ile | 100 %ile | ||
biomesight | 32.69 | 0 | 60 | 10 | 560 | 0 | 1071 | 330.6 | 210 | 377.5 | 0 | 670 | 0 %ile | 91.5 %ile |
thorne | 75.86 | 1 | 1335 | 0 | 666 | 91.3 | 4 | 293.4 | 0 | 55 | 0 %ile | 100 %ile | ||
thryve | 26.26 | 0 | 24 | 1 | 3218 | 0 | 972 | 270 | 154 | 358.3 | 0 | 552 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
XenoGene | 0 | 1000 | 0 | 0.1 |
GanzImmun Diagostics | 10 | 990000 | 0.001 | 99 |
Medivere | 10 | 990000 | 0.001 | 99 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 34.672 % | 0.031 % | 0.035 % | 993.0 | 2864 |
BiomeSightRdp | 12.5 % | 0.038 % | 0.018 % | 4.0 | 32 |
CerbaLab | 66.667 % | 0.002 % | 0.003 % | 2.0 | 3 |
CosmosId | 6.25 % | 0.002 % | 0.001 % | 2.0 | 32 |
custom | 18.644 % | 0.031 % | 0.014 % | 11.0 | 59 |
es-xenogene | 72.414 % | 0.011 % | 0.013 % | 21.0 | 29 |
GanzimmunDiag | 100 % | 0.039 % | 0 % | 3.0 | 3 |
Medivere | 71.429 % | 0.01 % | 0.017 % | 5.0 | 7 |
SequentiaBiotech | 16.667 % | 0.016 % | 0.006 % | 6.0 | 36 |
Thorne | 58.889 % | 0.006 % | 0.019 % | 53.0 | 90 |
Thryve | 25.018 % | 0.026 % | 0.033 % | 346.0 | 1383 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.